Syk Inhibits the Activity of Protein Kinase A by Phosphorylating Tyrosine 330 of the Catalytic Subunit
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Syk Inhibits the Activity of Protein Kinase A by Phosphorylating Tyrosine 330 of the Catalytic Subunit
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 288, Issue 15, Pages 10870-10881
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2013-02-28
DOI
10.1074/jbc.m112.426130
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sensitive kinase assay linked with phosphoproteomics for identifying direct kinase substrates
- (2012) L. Xue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger
- (2011) P. A. Insel et al. Acta Physiologica
- Direct modulation of the protein kinase a catalytic subunit α by growth factor receptor tyrosine kinases
- (2011) George B. Caldwell et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Cyclic-AMP-dependent protein kinase A regulates apoptosis by stabilizing the BH3-only protein Bim
- (2010) Diane Moujalled et al. EMBO REPORTS
- In-depth Analyses of Kinase-dependent Tyrosine Phosphoproteomes Based on Metal Ion-functionalized Soluble Nanopolymers
- (2010) Anton B. Iliuk et al. MOLECULAR & CELLULAR PROTEOMICS
- Syk and pTyr'd: Signaling through the B cell antigen receptor
- (2009) Robert L. Geahlen BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
- (2009) J. W. Friedberg et al. BLOOD
- A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell Survival
- (2009) Anurag Singh et al. CANCER CELL
- Proteomic and Genetic Approaches Identify Syk as an AML Target
- (2009) Cynthia K. Hahn et al. CANCER CELL
- Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest
- (2009) O. Bailet et al. CANCER RESEARCH
- Spleen Tyrosine Kinase Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia
- (2009) Maike Buchner et al. CANCER RESEARCH
- Novel phosphotyrosine targets of FGFR2IIIb signaling
- (2009) Yongde Luo et al. CELLULAR SIGNALLING
- Role of the Protein Tyrosine Kinase Syk in Regulating Cell-Cell Adhesion and Motility in Breast Cancer Cells
- (2009) X. Zhang et al. MOLECULAR CANCER RESEARCH
- The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCδ and proteasome-dependent regulation of Mcl-1 expression
- (2009) A D Baudot et al. ONCOGENE
- The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells
- (2009) Q Zhou et al. ONCOGENE
- A chimeric mechanism for polyvalenttrans-phosphorylation of PKA by PDK1
- (2009) Robert A. Romano et al. PROTEIN SCIENCE
- Comparative surface geometry of the protein kinase family
- (2009) Elaine E. Thompson et al. PROTEIN SCIENCE
- Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target
- (2008) R. M. Young et al. BLOOD
- Growth Suppression of Lung Cancer Cells by Targeting Cyclic AMP Response Element-Binding Protein
- (2008) S. Aggarwal et al. CANCER RESEARCH
- Protein kinase A as a biological target in cancer therapy
- (2008) Silvio Naviglio et al. EXPERT OPINION ON THERAPEUTIC TARGETS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started